Skip to main content

Table 4 Comparison of changes in lab results between the progression and non-progression groups

From: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study

Difference value of Variables Progression group
(n = 198)
Non-progression group
(n = 168)
p value
Glucose 0.21 ± 2.20 −0.19 ± 1.27 0.136
OGTT −0.42 ± 3.92 −0.67 ± 2.87 0.025
Insulin 6.00 ± 23.46 2.42 ± 11.90 0.347
Insulin2h 20.75 ± 58.80 14.65 ± 49.81 0.200
SBP −6.80 ± 21.76 2.68 ± 19.54 0.327
DBP −5.65 ± 11.95 −1.58 ± 13.80 0.637
PP −1.15 ± 18.76 4.26 ± 15.99 0.925
MAP −6.03 ± 13.22 −0.16 ± 14.05 0.517
HbA1c 0.17 ± 1.28 0.02 ± 0.97 0.339
hsCRP −4.61 ± 18.68 −11.19 ± 21.90 0.659
BUN 0.22 ± 1.39 0.48 ± 1.85 0.525
Creatinine 3.33 ± 16.63 4.28 ± 10.42 0.948
UA 20.25 ± 49.91 41.06 ± 70.41 0.311
GFR −3.17 ± 12.38 −5.90 ± 14.05 0.520
Urine Malb/Cr 0.89 ± 66.12 0.20 ± 1.83 0.491
TG −0.29 ± 0.91 −0.36 ± 1.58 0.279
TC −0.90 ± 0.91 −0.57 ± 1.09 0.285
LDL 0.16 ± 0.43 0.16 ± 0.30 0.321
HDL 0.02 ± 0.22 0.06 ± 0.21 0.124
Lpa −0.01 ± 0.09 0.14 ± 0.59 0.114
ApoA 0.02 ± 0.23 0.11 ± 0.25 0.919
ApoB −0.09 ± 0.26 −0.08 ± 0.23 0.609
LVEF −1.05 ± 5.65 −0.43 ± 5.83 0.561
  1. We calculate the changes in laboratory results by deducting the index value from the follow-up value.